Effects of Tiotropium and Salmeterol/Fluticasone Propionate on Airway Wall Thickness in Chronic Obstructive Pulmonary Disease

Publisher： Karger

E-ISSN： 1423-0356|86|4|280-287

ISSN： 0025-7931

Source： Respiration, Vol.86, Iss.4, 2013-07, pp. : 280-287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of fluticasone propionate inhalation on levels of arachidonic acid metabolites in patients with chronic obstructive pulmonary disease

By Verhoeven Gert T. Garrelds Ingrid M. Hoogsteden Henk C. Zijlstra Freek J.

Mediators of Inflammation, Vol. 10, Iss. 1, 2001-02 ,pp. : 21-26

Informa Healthcare

Access to resources Recommend Favorite

Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain

By Rutten-van Mölken Maureen Oostenbrink Jan Miravitlles Marc Monz Brigitta

The European Journal of Health Economics, Vol. 8, Iss. 2, 2007-06 ,pp. : 123-135

Springer Publishing Company

Access to resources Recommend Favorite

Economic evaluation of tiotropium and salmeterol in the treatment of chronic obstructive pulmonary disease (COPD) in Greece

By Maniadakis Nikos Tzanakis Nikolaos Fragoulakis Vassilis Hatzikou Magdalini Siafakas Nikolaos

Current Medical Research and Opinion, Vol. 22, Iss. 8, 2006-08 ,pp. : 1599-1607

Informa Healthcare

Access to resources Recommend Favorite

Effects of Salmeterol on Sleeping Oxygen Saturation in Chronic Obstructive Pulmonary Disease

Respiration, Vol. 79, Iss. 6, 2009-08 ,pp. : 475-481

Karger

Access to resources Recommend Favorite

Tiotropium for the treatment of chronic obstructive pulmonary disease

By Tashkin Donald P

Clinical Practice, Vol. 10, Iss. 2, 2013-03 ,pp. : 141-155

Future Medicine

Access to resources Recommend Favorite